Clinical Research Grants are designed to support both clinical trials of compounds already on the market and clinical studies performed at academic medical centers. Phase I and Phase IIa trials of novel therapeutics should be submitted as MDA Venture Philanthropy projects. All trials and studies must be FDA approved (if appropriate), and approved through an Institutional Review Board. MDA will only support such studies if they are performed to the highest ethical standards, and if the protocol is designed so as to gather the maximum amount of data.
Muscular Dystrophy Association — USA
222 S. Riverside Plaza, Suite 1500
Chicago, Illinois 60606
The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization.
©2015, Muscular Dystrophy Association Inc. All rights reserved.